2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Efficacy of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (VENUS)eye disorder, macular degeneration, retinal degeneration, retinal disorderActive, not recruitingPhase 22026-03-06NCT06196840
LX102 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)eye disorder, macular degeneration, retinal degeneration, retinal disorderActive, not recruitingPhase 12025-07-01NCT06198413